The announcement is made by Genor Biopharma Holdings Limited (the “Company”, together with its subsidiaries, the “Group”) on a voluntary basis to inform the shareholders and potential investors of the Company about the latest business updates of the Group.
Shanghai-based Genor Biopharma, which made a successful debut on Hong Kong stock exchange on Wednesday, is looking to offer cheaper treatments for breast cancer – the most common among all cancers in Chinese women.